blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1732544

EP1732544 - TREATMENT OF TREMOR WITH HISTAMINE H3 INVERSE AGONISTS OR HISTAMINE H3 ANTAGONISTS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  06.11.2009
Database last updated on 03.10.2024
Most recent event   Tooltip06.11.2009Withdrawal of applicationpublished on 09.12.2009  [2009/50]
Applicant(s)For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
[2006/51]
Inventor(s)01 / MARINO, Michael, J.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
02 / SEABROOK, Guy, R.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
 [2006/51]
Representative(s)Man, Jocelyn, et al
Merck & Co., Inc.
European Patent Department
Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU / GB
[N/P]
Former [2006/51]Man, Jocelyn, et al
Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU / GB
Application number, filing date05732633.222.03.2005
[2006/51]
WO2005US09562
Priority number, dateUS20040556803P26.03.2004         Original published format: US 556803 P
US20040561188P09.04.2004         Original published format: US 561188 P
US20040629099P18.11.2004         Original published format: US 629099 P
[2006/51]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005097111
Date:20.10.2005
Language:EN
[2005/42]
Type: A2 Application without search report 
No.:EP1732544
Date:20.12.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 20.10.2005 takes the place of the publication of the European patent application.
[2006/51]
Search report(s)International search report - published on:US27.04.2006
ClassificationIPC:A61K31/445
[2007/11]
CPC:
A61K31/4172 (EP,US); A61K31/445 (EP,US); A61P25/14 (EP)
Former IPC [2006/51]A61K31/4172
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/51]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:BEHANDLUNG VON TREMOR MIT HISTAMIN-H3-INVERSEN AGONISTEN ODER HISTAMIN-H3-ANTAGONISTEN[2006/51]
English:TREATMENT OF TREMOR WITH HISTAMINE H3 INVERSE AGONISTS OR HISTAMINE H3 ANTAGONISTS[2006/51]
French:TRAITEMENT DES TREMBLEMENTS UTILISANT DES AGONISTES INVERSES DE L'HISTAMINE H3 OU DES ANTAGONISTES DE L'HISTAMINE H3[2006/51]
Entry into regional phase26.10.2006National basic fee paid 
26.10.2006Search fee paid 
27.10.2006Designation fee(s) paid 
27.10.2006Examination fee paid 
Examination procedure27.10.2006Examination requested  [2006/51]
03.11.2009Application withdrawn by applicant  [2009/50]
Fees paidRenewal fee
05.03.2007Renewal fee patent year 03
10.03.2008Renewal fee patent year 04
13.03.2009Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US5486526  (DURANT GRAHAM J [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.